Pfizer Says JAKs Have Their Place Despite Xeljanz Safety Issues

 
• By Jessica Merrill
Pillars with vintage style filter
Pfizer says its JAK growth pillar remains strong • Source: Shutterstock

More from Earnings

More from Business